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ABSTRACT
Macroautophagy/autophagy is an intracellular degradation process that delivers cytosolic materials and/ 
or damaged organelles to lysosomes. De novo synthesis of the autophagosome membrane occurs within 
a phosphatidylinositol-3-phosphate-rich region of the endoplasmic reticulum, and subsequent expan-
sion is critical for cargo encapsulation. This process is complex, especially in mammals, with many 
regulatory factors. In this study, by utilizing PRKN (parkin RBR E3 ubiquitin protein ligase)-mediated 
mitochondria autophagy (mitophagy)-inducing conditions in conjunction with chemical crosslinking and 
mass spectrometry, we identified human BCAS3 (BCAS3 microtubule associated cell migration factor) 
and C16orf70 (chromosome 16 open reading frame 70) as novel proteins that associate with the 
autophagosome formation site during both non-selective and selective autophagy. We demonstrate 
that BCAS3 and C16orf70 form a complex and that their association with the phagophore assembly site 
requires both proteins. In silico structural modeling, mutational analyses in cells and in vitro phosphoi-
nositide-binding assays indicate that the WD40 repeat domain in human BCAS3 directly binds phos-
phatidylinositol-3-phosphate. Furthermore, overexpression of the BCAS3-C16orf70 complex affects the 
recruitment of several core autophagy proteins to the phagophore assembly site. This study demon-
strates regulatory roles for human BCAS3 and C16orf70 in autophagic activity.
Abbreviations: AO: antimycin A and oligomycin; Ash: assembly helper; ATG: autophagy-related; BCAS3: 
BCAS3 microtubule associated cell migration factor; C16orf70: chromosome 16 open reading frame 70; 
DAPI: 4‘,6-diamidino-2-phenylindole; DKO: double knockout; DMSO: dimethyl sulfoxide; ER: endoplasmic 
reticulum; fluoppi: fluorescent-based technology detecting protein-protein interactions; FIS1: fission, 
mitochondrial 1; FKBP: FKBP prolyl isomerase family member 1C; FRB: FKBP-rapamycin binding; hAG: 
humanized azami-green; IP: immunoprecipitation; IRES: internal ribosome entry site; KO: knockout; 
MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MFN2: mitofusin 2; MS: mass 
spectrometry; MT-CO2: mitochondrially encoded cytochrome c oxidase II; mtDNA: mitochondrial DNA; 
OPTN: optineurin; PFA: paraformaldehyde; PE: phosphatidylethanolamine; PtdIns3K: phosphatidylinositol 
3-kinase; PtdIns3P: phosphatidylinositol-3-phosphate; PtdIns(3,5)P2: phosphatidylinositol-3,5-bispho-
sphate; PINK1: PTEN induced kinase 1; PRKN/Parkin: parkin RBR E3 ubiquitin protein ligase; PROPPIN: 
β-propellers that bind polyphosphoinositides; RB1CC1/FIP200: RB1 inducible coiled-coil 1; TOMM20: 
translocase of outer mitochondrial membrane 20; ULK1: unc-51 like autophagy activating kinase 1; 
WDR45B/WIPI3: WD repeat domain 45B; WDR45/WIPI4: WD repeat domain 45; WIPI: WD repeat domain, 
phosphoinositide interacting; WT: wild type; ZFYVE1/DFCP1: zinc finger FYVE-type containing 1
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Introduction
Autophagy is an intracellular degradation pathway critical for 
cell homeostasis that delivers cytosolic materials and/or 
damaged organelles to lysosomes in response to various stres-
sors and signals [1,2]. Three types of autophagy have been 
identified: macroautophagy, microautophagy, and chaperone- 
mediated autophagy. Macroautophagy (hereafter referred to 
as autophagy) is distinguished by de novo membrane synth-
esis. In mammals, autophagy activation triggers synthesis of 
an phagophore, within a particular region of the endoplasmic
reticulum (ER). The phagophore then elongates and encapsu-
lates cellular components targeted for degradation by forming 
an enclosed double-membrane structure called the autopha-
gosome. Fusion of the autophagosome with lysosomes results 
in hydrolytic degradation of the autophagic cargo and subse-
quent recycling.
More than 35 proteins are essential for autophagy [3]. The 
earliest steps in the autophagy process require the ULK (unc- 
51-like autophagy activating kinase) complex, which is com-
posed of ULK1/2, RB1CC1 (RB1 inducible coiled-coil 1),
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ATG13 (autophagy related 13) and ATG101 [4,5]. Under 
nutrient-rich conditions, this complex is maintained in an 
inactivated state by MTOR (mechanistic target of rapamycin 
kinase) complex 1. Under starvation conditions, the inhibitory 
block is removed and the activated ULK complex promotes 
the recruitment of the class III phosphatidylinositol 3-kinase 
(PtdIns3K) complex, which consists of PIK3C3/VPS34, 
BECN1 (beclin 1), ATG14, NRBF2 and PIK3R4/VPS15, to 
the ER [6]. The phosphatidylinositol-3-phosphate (PtdIns3P) 
generated by the PtdIns3K complex forms a PtdIns3P- 
enriched ER subdomain (i.e. the omegasome) that functions 
as a platform for nucleation and elongation of the phagophore 
as well as recruitment of a number of PtdIns3P-binding 
proteins. Although ZFYVE1 (zinc finger FYVE-type contain-
ing 1), which binds PtdIns3P through double FYVE domains, 
is used as a marker for the omegasome, its contribution to 
autophagy activity (at least in starvation-induced autophagy) 
remains unknown [7]. In contrast, the PROPPIN (β- 
propellers that bind polyphosphoinositides) family proteins, 
WIPI1 (WD repeat domain, phosphoinositide interacting 1) 
and WIPI2 (yeast Atg18 homologs), and WDR45B (WD 
repeat domain 45B) and WDR45 (yeast Hsv2 homologs) [8] 
coordinately function in expansion and maturation of the 
phagophore [9]. Initial formation of the autophagosome like-
wise involves ATG9A vesicles. Atg8-family proteins, which 
associate with the phagophore membrane following lipidation 
via an the ATG12–ATG5-ATG16L1 complex, are critical for 
closure of the phagophore [10] as well as lysosomal degrada-
tion of the inner membrane [11].
Autophagy proteins are evolutionarily conserved from 
yeast to humans. They were initially identified by genetic 
screens in the budding yeast Saccharomyces cerevisiae [12–14], 
and Caenorhabditis elegans [15]. More recently, siRNA- 
mediated gene silencing [16] and knockout (KO)-based gen-
ome-wide screens [17] have been carried out in mammalian 
cells. However, accessory components, whose single gene 
deletions only manifest as mild defects in autophagy activity, 
might be missed by these types of genetic screens.
Our understanding of both starvation-induced autophagy 
(representative of non-selective autophagy) and ubiquitin- 
dependent selective autophagy has been greatly expanded 
over the past decade. Furthermore, mitochondrial autophagy 
(mitophagy) mediated by PRKN (parkin RBR E3 ubiquitin 
protein ligase) and PINK1 (PTEN induced kinase 1) is one of 
the most extensively characterized selective autophagy path-
ways [18–21]. The E3 ligase PRKN and the mitochondrial 
kinase PINK1, which are causal for familial Parkinson disease, 
coordinately function to generate poly-ubiquitin chains on 
damaged mitochondria through ubiquitin phosphorylation. 
In response to a loss in the mitochondrial membrane poten-
tial, PINK1 accumulates on the outer mitochondrial mem-
brane (OMM) [22,23] and phosphorylates ubiquitin [24–27]. 
Cytosolic PRKN is then recruited to the damaged mitochon-
dria through direct interactions with phosphorylated ubiqui-
tin. PINK1 further phosphorylates the ubiquitin-like domain 
in PRKN to activate its E3 ligase activity. Through the action 
of a positive feedback amplification loop, a number of OMM 
proteins are subsequently ubiquitinated [28] and recognized 
by autophagy receptors. Two such autophagy receptors,
CALCOCO2 (calcium binding and coiled-coil domain 2) 
and OPTN (optineurin), were recently shown to recruit the 
ULK complex and the ATG9A vesicles, respectively, as well as 
the ATG8 family proteins via their LC3-interacting region 
motifs [29–32].
Although the requirement of autophagy receptors is 
unique to ubiquitin-dependent autophagy, the molecular 
mechanisms of the later step (i.e. autophagosome formation) 
are thought to be common to both selective and non-selective 
autophagy. PRKN-PINK1 mitophagy is thus an ideal system 
for elucidating biogenesis of the phagophore because mito-
phagy can be spatiotemporally regulated, at least in the con-
text of cell biology. For example, nucleation of the 
phagophore can be induced by addition of an uncoupler 
that dissipates mitochondrial membrane potential such that 
elongation of the phagophore is limited to regions near 
damaged mitochondria.
In this study, we took advantage of this experimental 
system in conjunction with mass spectrometry analysis to 
identify human BCAS3 (BCAS3 microtubule associated cell 
migration factor) and C16orf70 (chromosome 16 open read-
ing frame 70) as novel proteins that associate with the pha-
gophore assembly site in both non-selective and selective 
autophagy. We demonstrate that BCAS3 and C16orf70 form 
a complex, and that this interaction is mutually essential for 
association with the phagophore assembly site. Based on 
structural modeling, mutational analyses and lipid binding 
assays, we show that critical PtdIns3P-binding pockets reside 
in the WD40 repeat domain of human BCAS3. Furthermore, 
we report that overexpression of the BCAS3-C16orf70 com-
plex impedes recruitment of ATG13 and ATG16L1 to the 
phagophore assembly site. These results suggest human 
BCAS3 and C16orf70 regulate autophagy activity.
Results
Mass spectrometric identification of BCAS3 and C16orf70 
as WIPI1 co-immunoprecipitating proteins
Both ZFYVE1 and WIPI1 localize to the phagophore assem-
bly site in response to autophagy induction. We and others 
previously showed that ZFYVE1 and WIPI1 translocate from 
the cytosol to the phagophore assembly site in response to 
PRKN-mediated mitophagy [33,34]. Therefore, we sought to 
identify novel mammalian proteins that associate with 
damaged mitochondria and/or the phagophore assembly site 
during PRKN-mediated mitophagy by immunoprecipitating 
ZFYVE1 or WIPI1. For this purpose, single clones of HeLa 
cells stably expressing YFP-PRKN and 3FLAG-tagged 
ZFYVE1 (3FLAG-ZFYVE1) or WIPI1 (3FLAG-WIPI1) were 
isolated and mitophagy-dependent recruitment of ZFYVE1 
and WIPI1 to damaged mitochondria was confirmed (Figure 
1A). Cells treated with or without valinomycin were then 
crosslinked with 0.1% paraformaldehyde (PFA), co- 
immunoprecipitated with an anti-FLAG antibody, and the 
immunoprecipitated proteins were analyzed by mass spectro-
metry (MS) and label-free quantification. PFA-mediated 
crosslinking facilitated the capture of proteins that directly 
interact with ZFYVE1 and WIPI1 as well as proteins localized
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Figure 1. Co-IP followed by MS analysis of WIPI1-associated proteins during mitophagy identified human BCAS3 and C16orf70. (A) HeLa cells stably expressing YFP- 
PRKN and 3FLAG-ZFYVE1 or 3FLAG-WIPI1 were treated with dimethyl sulfoxide (DMSO; control) or valinomycin for 3 h and then immunostained. Bars: 20 µm. (B) 
After treatment with DMSO or valinomycin, the cells in (A) were treated with 0.1% PFA, solubilized, and co-immunoprecipitated with an anti-FLAG/DDDDK antibody 
and then analyzed by MS. The volcano plots (ZFYVE1-IP – upper panel; WIPI1-IP – lower panel) show the abundance ratios (valinomycin versus control) plotted 
against the p-value in a – log10 scale for three independent experiments. Yellow dots indicate autophagy-related proteins listed in (C) and red dots indicate BCAS3 
and C16orf70. (C) Co-IP proteins in (B) were ranked according to the Proteome Discoverer software-based quantification abundance ratio (valinomycin versus 
control). Protein designations are based on the UniProt database. Mitochondrial and autophagy-related proteins are highlighted in green and yellow, respectively.
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adjacent to damaged mitochondria and/or the phagophore 
assembly site. Significant enrichment was observed in 
a number of proteins (i.e. those with high abundance ratios) 
in the valinomycin-treated ZFYVE1-IP and WIPI1-IP samples 
relative to control (untreated) samples (Figure 1B). The top 35 
most abundant proteins in the valinomycin-treated samples 
included core autophagy proteins (ATG2B, WDR45, ATG14, 
ATG101, ATG16L1 and WIPI2), autophagy-related proteins 
(WHAMM [WASP homolog associated with actin, golgi 
membranes and microtubules] and JMY [junction mediating 
and regulatory protein, p53 cofactor]) [35,36], autophagy 
receptors (OPTN) [37,38], and the ubiquitin-related proteins 
(UBB [ubiquitin B] and USP4 [ubiquitin specific peptidase 4]). 
The presence of these proteins in our screen confirmed the 
utility of our approach for efficiently capturing proteins in 
close proximity to the mitophagy-specific phagophore assem-
bly site (Figure 1C). We also identified a number of mito-
chondrial proteins (Figure 1C) that likely correspond to 
precursor proteins that had accumulated on the outer mito-
chondrial surface rather than the matrix as valinomycin- 
induced loss in membrane potential blocks protein transloca-
tion into the matrix. To validate the MS-based results and 
identify novel autophagy-related proteins, non-mitochondrial 
candidate proteins were individually tested for mitochondrial 
recruitment during PRKN-mediated mitophagy (Fig. S1). 
Although the subcellular localization of most of the proteins 
tested did not change (Fig. S1), signals for several small 
GTPases, including RAB1A (RAB1A, member RAS oncogene 
family), RAB1B, RAB24, and SAR1B (secretion associated Ras 
related GTPase 1B), were detected in close proximity to the 
damaged mitochondria as reported previously [39–41]. 
Signals for 3FLAG-tagged BCAS3/Rudhira and C16orf70 dis-
persed throughout the cytosol under normal conditions, but 
accumulated around damaged mitochondria in response to 
valinomycin treatment (Figure 2A and Fig. S2A). Mammalian 
BCAS3 is a cytoskeletal protein essential for development of 
angiogenesis [42–44] and C16orf70 gene has been reported to 
undergo hypermethylation in male schizophrenia patients 
[45]. The molecular function of these proteins in autophagy, 
however, is unknown.
Although both BCAS3 and C16orf70 formed punctate 
structures adjacent to the damaged mitochondria in response 
to mitophagy stimulation, these structures did not appear in 
HeLa cells in the absence of PRKN overexpression or in 
siRNA PINK1-suppressed cells even after 3 h of valinomycin 
treatment (Figure 2B; Fig. S2B and S2C). This suggests that 
the mitochondrial recruitment of BCAS3 and C16orf70 
depends on PRKN and PINK1. To gain insights into the 
mitochondrial recruitment of endogenous BCAS3, we pro-
duced an anti-BCAS3 antibody. Immunocytochemistry with 
this antibody showed that both exogenous and endogenous 
BCAS3 concentrated near damaged mitochondria in a PRKN- 
mediated mitophagy-dependent manner (Figure 2C; Fig. 
S2D). Furthermore, unlike the mitochondrial proteins; 
TOMM20 (translocase of outer mitochondrial membrane 
20) and MFN2 (mitofusin 2), BCAS3 and C16orf70 are not 
ubiquitinated or degraded by mitophagy induction 
(Figure 2D).
BCAS3 and C16orf70 form a heterodimer
While determining the subcellular localization of 
BCAS3 and C16orf70, we noticed that under basal con-
ditions the BCAS3 and C16orf70 signals resolved as 
weak dot-like structures that were almost completely 
merged (Figure 3A), suggesting that they form 
a complex. To test this possibility, we performed 
a fluoppi (fluorescent-based technology detecting pro-
tein-protein interactions) assay [25,46,47]. When 
a protein fused with a homo-tetrameric humanized 
azami green (hAG) interacts with another protein that 
is fused with a homo-oligomeric assembly helper (Ash), 
they form large fluorescent foci in cells through multi-
valent interactions. hAG-tagged BCAS3 (hAG-BCAS3) 
generates a diffuse cytosolic signal when expressed 
with the HA-Ash vector (Figure 3B). In sharp contrast, 
when hAG-BCAS3 was expressed with HA-Ash-tagged 
C16orf70 (HA-Ash-C16orf70), foci were formed (Figure 
3B). To further examine this interaction, we also used 
the FRB (FKBP-rapamycin binding)-FKBP (FKBP prolyl 
isomerase family member 1C) system in which the two 
proteins dimerize in the presence of rapamycin [48]. We 
anchored the FRB domain to the mitochondria by fus-
ing it with the transmembrane segment of FIS1 (fission, 
mitochondrial 1) and forced heterotropic mitochondrial 
localization of FKBP-tagged BCAS3 (BCAS3-2FKBP) by 
addition of rapamycin-analog (rapalog) (Figure 3C). In 
the absence of BCAS3-2FKBP, C16orf70-3FLAG loca-
lizes in the cytosol irrespective of rapalog treatment 
(Figure 3C). However, when cytosolic BCAS3-2FKBP 
was forced to associate on mitochondria after 3 h of 
rapalog treatment, C16orf70-3FLAG also moved to the 
mitochondria (Figure 3C), indicating that BCAS3 and 
C16orf70 interact with each other even under basal 
conditions. We also performed co- 
immunoprecipitation assays to confirm the BCAS3- 
C16orf70 interaction occurs regardless of mitophagy 
induction (Figure 3D and 3E). It should be noted that 
although ZFYVE1 and WIPI1 were used as baits in the 
initial MS-IP analysis, neither was pulled down with 
FLAG-tagged BCAS3 or C16orf70 without a chemical 
crosslinker (Figure 3D and 3E). Based on these assays, 
we conclude that BCAS3 and C16orf70 form 
a heterodimer under both normal growing and mito-
phagy-inducing conditions.
Taking further advantage of the fluoppi assay, we next used 
BCAS3 truncation mutants to determine the region of BCAS3 
responsible for C16orf70 interactions. In general, the fluores-
cence intensity of the fluoppi foci correlates with the strength 
of the protein-protein interaction. Thus, we classified BCAS3- 
C16orf70 interactions based on the size of the resulting foci as 
“none” for no foci, “weak” for small foci, and “strong” for 
large foci. The structure prediction algorithm HHpred sug-
gested residues 58–644 of BCAS3 correspond to a WD40 
repeat domain. To assess the potential functional role of this 
region, we generated two BCAS3 mutants (residues 1–471 and 
1–644) that lose the C-terminal parts but retain the predicted 
WD40 repeat domain, as well as three BCAS3 mutants
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(residues 472–913, 553–913, and 645–913) that lose the 
N-terminal parts. hAG fusion with full-length wild type 
(WT) BCAS3 efficiently formed fluoppi foci with HA-Ash- 
C16orf70. Similarly, all of the N-terminal truncations (i.e.
residues 472–913, 553–913, and 645–913) formed foci albeit 
less efficiently than WT (Figure 3F; Fig. S3). In contrast, no 
foci were formed with the 1–471 mutant, and the 
1–644 mutant only formed small foci, suggesting that the
Figure 2. BCAS3 and C16orf70 are recruited to the phagophore assembly site upon mitophagy in a PRKN-PINK1 dependent manner. (A and B) HeLa cells stably 
expressing 3FLAG-BCAS3 or C16orf70-3FLAG with (A) or without YFP-PRKN (B) were treated with DMSO or valinomycin for 3 h and then immunostained. Bars: 20 µm. 
(A) Magnified images are shown in the rightmost panels. (C) HCT116 cells stably expressing GST-PRKN were treated with DMSO or valinomycin for 3 h and then 
immunostained. Endogenous BCAS3 was detected with an anti-BCAS3 antibody. Bars: 10 µm. (D) Total cell lysates in (A) were analyzed by western blotting. 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. Orange arrowheads denote ubiquitinated TOMM20.
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Figure 3. BCAS3 and C16orf70 interact with each other. (A) 3HA-BCAS3, C16orf70-3FLAG and GST-PRKN were stably expressed in HeLa cells. Cells were treated with
2016 W. KOJIMA ET AL.
C-terminal region of BCAS3 is important for C16orf70 inter-
actions (Figure 3F; Fig. S3). To further narrow down the 
interaction region, we generated a series of 40 aa deletions 
spanning residues 472–913 of full-length BCAS3. With the 
exception of Δ680–719, all of the constructed deletion 
mutants (Δ472–559, Δ560–599, Δ600–639, Δ640–679, 
Δ680–719, Δ720–759, Δ760–799, Δ800–839, Δ840–879, and 
Δ880–913) formed foci similar to WT. Although the 
Δ680–719 deletion did not abolish foci formation, the foci 
size was clearly reduced. Furthermore, inserting the Δ680–719 
deletion into the N-terminal truncation mutants completely 
inhibited foci formation (Figure 3F; Fig. S3). These results 
suggest that residues 680–719 of BCAS3 are important for 
C16orf70 interactions. We further analyzed the BCAS3- 
C16orf70 interaction by co-IP. HA-tagged WT BCAS3 and 
the mutants shown in Figure 3F were co-expressed with 
FLAG-tagged C16orf70 in HeLa cells and cell extracts were 
immunoprecipitated with an anti-FLAG antibody. We first 
confirmed that full-length WT BCAS3 and the 472–913, but 
not the 1–471, were efficiently pulled down with FLAG- 
C16orf70 (Figure 3G). Furthermore, consistent with the 
fluoppi results, interactions of the BCAS3 472–913 and 
553–913 mutants with C16orf70 were completely lost when 
the Δ680–719 deletion was introduced. We also noticed that 
the protein level of exogenous C16orf70 was stabilized by 
interactions between BCAS3 and C16orf70 (Figure 3G input 
of FLAG-C16orf70). From these two independent assays (i.e. 
the fluoppi assay and co-IP), we concluded that residues 
680–719 of BCAS3 are crucial for C16orf70 interactions and 
that other regions in the BCAS protein likely stabilize those 
interactions.
Interactions between BCAS3 and C16orf70 are essential 
for accumulating around damaged mitochondria
Since BCAS3 and C16orf70 form a complex, we next tested 
whether the interaction is required for their recruitment 
around mitochondria in response to PRKN-mediated mito-
phagy. For this purpose, we established BCAS3-/- and 
C16orf70-/- HCT116 cell lines using CRISPR-Cas9 gene edit-
ing methods (see details in Materials and Methods), and then 
stably expressed C16orf70-3FLAG and 3HA-BCAS3 in the cell 
lines along with GST-PRKN. In WT HCT116 cells, BCAS3 
and C16orf70 were observed as punctate structures around 
mitochondria under mitophagy-inducing conditions (Figure 
4A and 4B). In C16orf70-/- cells, however, 3HA-BCAS3 did
not accumulate around the damaged mitochondria (Figure 4A 
and 4C). Similar defects in the mitochondrial recruitment of 
C16orf70 were observed in BCAS3-/- cells (Figure 4B and 4C). 
These defective phenotypes were observed in all of the 
BCAS3-/- and C16orf70-/- clones generated (Fig. S4A and 
S4B). Importantly, exogenous BCAS3 expression in BCAS3-/- 
cells and exogenous C16orf70 expression in C16orf70-/- cells 
recovered the accumulation of C16orf70 and BCAS3, respec-
tively, around the damaged mitochondria (Figure 4A – 4C). 
These results indicate that BCAS3 and C16orf70 are mutually 
dependent for their accumulation around damaged 
mitochondria.
BCAS3-C16orf70 complex is associated with the 
phagophore assembly site during PRKN-mediated 
mitophagy
Following a loss in membrane potential, PRKN molecules 
associated with damaged mitochondria colocalize with 
TOMM20 [49]. In contrast, signals for BCAS3 near damaged 
mitochondria appeared as dot-like and/or cup-shaped struc-
tures (Figure 5A), raising the possibility of direct association 
with phagophores or the phagophore assembly site rather 
than mitochondria. To address this possibility, we next used 
fluorescent microscopy methods to examine colocalization of 
3 HA-BCAS3 with autophagy core proteins. The autophagy- 
initiation complex, which consists of ULK1, RB1CC1, ATG13 
and ATG101, is essential for autophagy activation [33,50,51]. 
GFP-ULK1 formed mitophagy-dependent foci that clearly 
merged with some 3HA-BCAS3 puncta (Figure 5B). We 
next examined colocalization between BCAS3 and autophagy 
proteins containing PtdIns3P-binding domains. Following 
mitophagy stimulation, overexpressed GFP-ZFYVE1 and 
GFP-WIPI1 as well as endogenous WIPI2 were often found 
in cup-shaped structures that colocalized with the 3HA- 
BCAS3 signals (Figure 5C – 5E). Since PtdIns3P is generated 
within a particular region of the ER membrane, the cup- 
shaped structures are thought to comprise the phagophore 
assembly site [7]. ATG2A is known to act as a bridge between 
the ER and the phagophore via direct interactions with WIPIs 
[52,53]. Colocalization of BCAS3 and ATG2AΔC, a C- 
terminal deletion that enables selective association with the 
phagophore by inhibiting localization on lipid droplets [54], 
also suggested that BCAS3 is recruited to the phagophore 
assembly site (Figure 5F). A similar colocalization pattern 
was observed with BCAS3 and ATG16L1; however,
DMSO or valinomycin for 3 h and then immunostained. Magnified images are shown in the rightmost panels. Bars: 20 µm. (B) hAG-BCAS3 was expressed with either 
an HA-Ash vector or HA-Ash-C16orf70 in HeLa cells. Cells were immunostained 24 h post-transfection. Nuclei were stained with DAPI. Bars: 20 µm. (C) The indicated 
proteins were co-expressed with FRB-FIS1TM in HeLa cells. Cells were treated with ethanol (EtOH, control) or rapalog for 3 h and then immunostained. Bars: 20 µm. 
(D and E) 3HA-tagged C16orf70, BCAS3, ZFYVE1, or WIPI1 were transiently expressed in HeLa cells stably expressing 3FLAG-BCAS3 or C16orf70-3FLAG. After 24 h of 
transfection, cells were immunoprecipitated with an anti-FLAG antibody. The input (30% against the bound fraction) and the bound fractions were analyzed by 
western blotting. TOMM20 was used as a negative control. (F) Summary of results from fluoppi assays using the BCAS3 constructs. Truncated or deleted regions in 
BCAS3 are shown in gray. hAG-tagged WT BCAS3 and associated mutants were transiently expressed with HA-Ash-C16orf70 in HeLa cells and immunostained (Fig. 
S4B). Graphs show the percentage (%) of cells with the indicated fluoppi foci (none, weak, or strong). Error bars represent mean ± s.d. with > 100 cells counted in 
each of three independent experiments. (G) HEK293 cells expressing 3FLAG-C16orf70 and the indicated 3HA-BCAS3 truncated mutants were immunoprecipitated 
using an anti-FLAG antibody. The input (30% against the bound fraction) and the bound fractions were analyzed by western blotting. TOMM20 was used as 
a negative control.
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ATG16L1 signals were more frequently observed with BCAS3 
as an enclosed cup-shape (Figure 5G). MAP1LC3B is known 
to associate with elongating phagophores as well as enclosed 
autophagosomal membranes. Although a portion of the 
MAP1LC3B signal colocalized with BCAS3, not all 
MAP1LC3B signals aligned with BCAS3 (Figure 5H). To 
further examine colocalization of the BCAS3-C16orf70 com-
plex with endogenous WIPI2 or MAP1LC3B, we constructed 
a HeLa cell line stably expressing C16orf70-3HA and 
untagged BCAS3 using the IRES (internal ribosome entry 
site) system and used a super-resolution confocal microscope 
to image the immunostained cells. As shown in Figure 5I and 
5J, the BCAS3-C16orf70 complex completely merged with 
WIPI2, but not MAP1LC3B, suggesting preferential localiza-
tion of the BCAS3-C16orf70 complex to the phagophore 
assembly site rather than enclosed autophagosomal 
membranes.
BCAS3-C16orf70 complex is recruited to the phagophore 
assembly site in response to starvation
We next sought to determine if BCAS3 and C16orf70 recruit-
ment to the phagophore assembly site is mitophagy specific or 
if the two proteins can also be recruited in response to non- 
selective autophagy conditions. To address this question, we 
examined the localization of BCAS3 and C16orf70 under 
amino-acid starvation condition. When the cells were incu-
bated in media without amino acids for 1 h, a number of 
BCAS3 and C16orf70 puncta appeared (Figure 6A). In addi-
tion, MAP1LC3B was consistently observed adjacent to the 
BCAS3-C16orf70 puncta (Figure 6B). Furthermore, endogen-
ous BCAS3 clearly colocalized with GFP-ULK1 in response to 
starvation (Figure 6C). These results indicate that the BCAS3- 
C16orf70 complex is recruited to the phagophore assembly 
site irrespective of cargo during both non-selective and selec-
tive autophagy.
Figure 4. BCAS3 and C16orf70 are mutually dependent for accumulating around damaged mitochondria. (A and B) GST-PRKN and the indicated proteins were stably 
expressed in WT, C16orf70-/-, and BCAS3-/- HCT116 cells. Cells were treated with or without valinomycin for 3 h and then immunostained. 3HA-BCAS3, C16orf70-3FLAG 
and GST-PRKN were detected with anti-HA, anti-FLAG/DDDDK, and anti-PRKN antibodies, respectively. Bars: 10 µm. (C) The degree of mitophagy-dependent 
mitochondrial recruitment of 3HA-BCAS3 in (A) and C16orf70-3FLAG in (B) was quantified. Each dot represents the mean value determined from >100 cells and error 
bars represent mean ± s.d. in three independent experiments. Statistical differences were determined by student’s t-test (n.s.: not significant; ***P < 0.001).
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Figure 5. BCAS3 colocalizes with autophagy proteins in response to mitophagy. (A-H) HeLa cells stably expressing 3FLAG-BCAS3 and HA-PRKN (A), 3HA-BCAS3, GFP- 
ULK1 and GST-PRKN (B), 3HA-BCAS3, GFP-ZFYVE1 and GST-PRKN (C), 3HA-BCAS3, GFP-WIPI1 and GST-PRKN (D), 3HA-BCAS3 and GST-PRKN (E and G), 3HA-BCAS3, 
3FLAG-ATG2AC and GST-PRKN (F), and HCT116 cells stably expressing 3FLAG-BCAS3 and HA-PRKN (H) were treated with DMSO or valinomycin for 3 h and then 
immunostained. Magnified images are shown in the rightmost panels. Bars: 20 µm. (I and J) HeLa cells stably expressing untagged PRKN and the C16orf70-3HA- 
BCAS3 complex (C16-3HA/BCAS3) using an IRES system were treated with valinomycin for 3 h and then immunostained. The z-stack images were taken with an SP8 
confocal microscope and processed for deconvolution and maximum projection. Magnified images are shown to the right. Bars: 10 µm.
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Figure 6. BCAS3 and C16orf70 colocalize with MAP1LC3 during starvation-induced autophagy. (A and B) HCT116 cells stably expressing BCAS3 and C16orf70-3HA 
from an IRES system (A) or 3HA-BCAS3 (B) were incubated in normal media (control) or amino-acid free media (starvation) for 1 h before immunostaining. Images are
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When autophagy is induced, autophagy core proteins are 
assembled at the phagophore assembly site in a hierarchical 
manner. Previous studies showed that deletion of the most 
upstream unit ULK complex impairs the assembly of the 
downstream factors such as WIPIs, whereas genetic depletion 
of ATG5, which is involved in the later steps of autophago-
some formation, results in an accumulation of WIPIs as 
enlarged foci at the phagophore assembly site [33]. 
Furthermore, STX17 (syntaxin 17), a SNARE (soluble 
N-ethylmaleimide sensitive fusion protein attachment protein 
receptor) for fusion of the autophagosome with the lysosome, 
is recruited to the autophagosome only after the autophago-
somal membrane has enclosed [55]. Additionally, in ubiqui-
tin-dependent selective autophagy, the autophagy receptors, 
CALCOCO2 (calcium binding and coiled-coil domain 2) and 
OPTN, hierarchically precede the ULK complex [31]. We thus 
assessed the pathway effects of BCAS3 under starvation con-
ditions using autophagy deficient ATG KO HCT116 cell lines 
and a PtdIns3K inhibitor. ATG13, the most upstream core 
ATG protein, is a critical subunit in the ULK complex. In 
ATG13-/- HCT116 cells, starvation-induced BCAS3 puncta 
were reduced compared to WT HCT116 cells (Figure 6D 
and 6E). Previous reports showed that deletion of the ATG5 
gene abrogates MAP1LC3 lipidation [56] and that several 
ATG proteins accumulate in ATG5 KO cells even under 
basal conditions [57]. Similar to WIPI1 [57], BCAS3 puncta 
were observed in ATG5-/- HCT116 cells and their quantity 
increased after 1 h of starvation (Figure 6D and 6E). In sharp 
contrast, no BCAS3 puncta were observed when cells were 
treated with the PtdIns3K inhibitor wortmannin prior to 
starvation (Figure 6D). These analyses strongly suggest that 
BCAS3 is positionally situated between ATG13 and ATG5 
and is recruited to either the phagophore assembly site or 
the elongating phagophore in a PtdIns3P-dependent manner 
similar to WIPI family proteins.
Structural modeling predicts that the WD40 repeat 
domain in BCAS3 contains phosphoinositide-binding 
pockets
As indicated above, human BCAS3 has a predicted 
N-terminal WD40 repeat domain. WD40 repeat domains are 
characterized by tandem repeats of 40–60 amino acids termi-
nating in a Trp-Asp (WD) dipeptide that form an encircled β- 
propeller structure and which act as scaffolds for protein- 
protein interactions as well as protein-DNA and protein- 
lipid interactions [58]. The WD40 repeat domain is one of 
the most abundant domains in eukaryotes and is conserved 
across diverse proteins including signaling factors, transcrip-
tion factors and autophagy proteins [59]. HHpred [60] pre-
dicts structural similarities between BCAS3 and Pichia 
angusta Atg18 (homolog of human WIPI1 and WIPI2) and
Kluyveromyces lactis Hsv2 (homolog of human WDR45B and 
WDR45) with high probability (e-value: 1.2e-18 and 2.4e-18, 
respectively) (Figure 7A). Atg18 and Hsv2 function in auto-
phagy and interact with PtdIns3P and/or PtdIns(3,5)P2 
through their WD40 repeat domains [61,62]. Furthermore, 
the crystal structure of the Hsv2 WD40 repeat domain 
(PDB: 4EXV) complexed with sulfate ions has been deter-
mined [63,64]. We thus modeled the human BCAS3 WD40 
repeat domain on the Hsv2 structure (Figure 7A and 7B). The 
predicted structure consists of a 7-bladed β-propeller with two 
inserts in blades 4 and 6 (Figure 7A and 7B), the latter of 
which includes predicted disordered regions. The insertion 
pattern is similar to that of yeast Atg18. Furthermore, the 
structural model suggests that the BCAS3 WD40 repeat 
domain binds two sulfate ions via interactions in sites 1 and 
2 (Figure 7B – 7D). Both sites correspond to a cluster of polar 
and charged residues: site 1 consists of H350, D370, L372, 
H377, and H400 in blade 5, whereas site 2 is formed by R401 
of blade 5 and R426, T428 and H430 of blade 6 (Figure 7C 
and 7D). These results and chemical similarities between the 
sulfate and phosphate ions imply that the two sites comprise 
the phosphoinositide-binding pockets (Figure 7D). When 
compared with K. lactis Hsv2 sites 1 and 2 [63], the critical 
phospholipid binding residues in Hsv2 are more conserved in 
site 2 than site 1 (Figure 7D).
Phosphoinositide binding is important for BCAS3 
association with the phagophore assembly site
Based on the structural prediction, we hypothesized that 
phosphoinositide phosphates are recognized by sites 1 and/ 
or 2. To determine if the predicted phosphoinositide-binding 
pockets are important for BCAS3 association with the phago-
phore assembly site, we replaced amino acid residues in the 
two sites with alanine. The resultant 3HA-tagged BCAS3 
mutants were expressed in BCAS3-/- cells and recruitment to 
the phagophore assembly site assessed in response to mito-
phagy. Under normal growing conditions, all of the mutants 
localized to the cytosol (Fig. S5A). Following mitophagy 
induction, two of the site 1 mutants, D370A and H400A, 
exhibited decreased efficiency of recruitment, whereas recruit-
ment of the other site 1 mutants (H350A, L372A, and H377A) 
was comparable to WT (Figure 8A and 8B). In contrast, site 2 
mutants were largely defective in mitophagy-dependent accu-
mulation of BCAS3 on the phagophore assembly site; minimal 
inhibition was seen with the R426A mutant and near com-
plete inhibition was seen with the R401A, T428A, and H430A 
mutants (Figure 8A and 8B). The alanine substitutions, how-
ever, may have adversely impacted C16orf70 interactions, 
which are essential for BCAS3 association with the phago-
phore assembly site (Figure 4). Therefore, to rule out this 
possibility, fluoppi assays were performed with the BCAS3
displayed as z-stacked confocal slices. Magnified images are shown in the rightmost panels. Bars: 10 µm. (C) HeLa cells stably expressing GFP-ULK1 were incubated 
as in (A). Bars: 20 µm. (D) WT, ATG13-/- and ATG5-/- HCT116 cells were incubated in normal media (control), amino-acid free media (starvation), or with wortmannin 
for 1 h prior to immunostaining. Endogenous BCAS3 was detected using an anti-BCAS3 antibody. Images are displayed as z-stacked confocal slices. Bars: 10 µm. (E) 
The number (left panel) and relative area (right panel) of BCAS3 foci in (D) were quantified. Each dot represents the mean value determined from >120 cells and error 
bars represent mean ± s.d. in three independent experiments. Statistical differences were determined by student’s t-test (n.s.: not significant; *P < 0.05; **P < 0.01).
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alanine mutants. As shown in Fig. S5B, all hAG-tagged 
BCAS3 mutants formed foci with HA-Ash-C16orf70. 
Consequently, dissociation of the BCAS3 mutants from the
phagophore assembly site does not result from defective 
C16orf70 interactions. We also tested whether the insertions 
in the WD40 repeat domain are critical for association with
Figure 7. Two phospholipid-binding sites are predicted in the BCAS3 WD40 repeat domain. (A) Predicted secondary structure for human BCAS3. The secondary 
structure in the WD40 repeat domain was assigned based on the model shown in (B) and secondary structure features in the N- and C-terminal regions were 
determined using PSIPRED [76]. Disordered regions were predicted using DISOPRED3 [77]. Lines, arrows, and dotted lines indicate helix, strand and disordered region, 
respectively. The two inserts in blades 4 and 6 are colored orange. (B) Predicted 3D structure of the human BCAS3 WD40 repeat domain. The two inserts in WD40 (i.e. 
residues 254–312 and 437–560) are deleted. Sites 1 and 2 (the predicted phospholipid-binding pockets) are colored magenta and blue, respectively. (C) Detailed 
sulfate binding depicted for sites 1 and 2. Side chains of the indicated residues in site 1 (magenta) and site 2 (blue) are depicted in ball-and-stick mode, whereas the 
sulfate ions are depicted as van der Waals spheres. (D) Alignment of the amino acid sequence around sites 1 and 2 of human BCAS3 and various Atg18 family 
proteins. Residues critical for phospholipid binding in K. lactis Hsv2 [63] are colored in red. Amino acid residues in sites 1 and 2 that were functionally examined in 
Figure 8 are highlighted in magenta and blue, respectively.
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the phagophore assembly site. The WD40 repeat domain was 
predicted to contain two insertions encompassing residues 
254–312 in blade 4 and residues 437–560 in blade 6. 
Deletion of the blade 4 insertion (Δ254–312) or the blade 6 
insertion (Δ437–560) completely abolished BCAS3 association 
with the phagophore assembly site during mitophagy (Figure
8A and 8B) without affecting C16orf70 interactions (Fig. S5B). 
Computational modeling and targeted mutation of predicted 
sites demonstrated that BCAS3 association with the phago-
phore assembly site depends on phosphoinositide-binding 
pockets (mainly site 2) and the two insertions in the WD40 
repeat domain.
Figure 8. Predicted BCAS3 phospholipid-binding sites and the two insert regions are essential for associating with the phagophore assembly site. (A) BCAS3-/- HCT116 
cells transiently expressing the indicated 3HA-BCAS3 construct with GST-PRKN were treated with valinomycin for 3 h and then immunostained. Bars: 10 µm. (B) The 
degree of BCAS3 mitochondrial recruitment in (A) was quantified. Each dot represents the mean value determined from >100 cells and error bars represent mean ± s. 
d. in three independent experiments.
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Overexpression of the BCAS3-C16orf70 complex retards 
recruitment of ATG13 and ATG16L1 to the phagophore 
assembly site
Are BCAS3 and C16orf70 required for autophagy? To address 
this question, we monitored mitophagy using a FACS (fluores-
cence-activated cell sorting) assay and DKO (double knockout) 
cell lines. For this purpose, YFP-PRKN and mitochondria- 
targeted Keima (mt-Keima) were stably expressed in WT and 
BCAS3-/-C16orf70-/- DKO HCT116 cells. Mitophagy-dependent 
delivery of mt-Keima to lysosomes can be monitored by FACS 
based on the pH-sensitive spectral shift of Keima [31,65]. Under 
basal growing conditions, all cell lines exhibited less than 2% 
mitophagy (Figure 9A and 9B). In contrast, when treated with 
antimycin A and oligomycin (AO) for 9 h, 83% of WT cells were 
mitophagy positive, and DKO clones #1-1-7 and #1-1-17 exhib-
ited 90–92% mitophagy (Figure 9A and 9B). In this assay, AO 
rather than valinomycin, was used to minimize the inhibition of 
lysosomal acidification. Since the slight enhanced mitophagy 
efficiencies in BCAS3-/- C16orf70-/- DKO cells did not change 
following the introduction of exogenous BCAS3-C16orf70 com-
plex (3HA-BCAS3 and C16orf70-3FLAG), the differences are 
likely attributable to clonal differences (Figure 9A and 9B). 
Mitophagy in the DKO cells was also detected by degradation 
of mitochondrial matrix proteins and mitochondrial DNA 
(mtDNA). AO treatment for 24 h decreased the OMM protein
TOMM20 as well as the matrix proteins MT-CO2 (mitochond-
rially encoded cytochrome c oxidase II) and PDHA1 (pyruvate 
dehydrogenase E1 subunit alpha 1) in a PRKN-dependent man-
ner (Fig. S6A). The reduced degradation of MT-CO2 and 
PDHA1 in ATG5-/- cells suggests that the process is autophagy 
dependent (Fig. S6A). Under these conditions, the mitochon-
drial degradation observed in two different BCAS3-/-C16orf70-/- 
DKO cell lines was comparable to the WT HCT116 cell line (Fig. 
S6A). Furthermore, genetic deletion of the BCAS3-C16orf70 
complex did not affect mtDNA degradation in response to 
PRKN-mediated mitophagy (Fig. S6B). We thus concluded 
that mitophagy is not affected by BCAS3 and/or C16orf70 gene 
deletions at least in cultured cells. We next tested if autophagy 
was impacted by overexpression of the BCAS3-C16orf70 com-
plex. Although both western blotting (Fig. S6C) and immuno-
cytochemistry (Fig. S6D) indicated that overexpression of the 
BCAS3-C16orf70 complex had little to no effect on mitochon-
drial degradation over 24 h, we found the subcellular distribu-
tions of some core autophagy proteins were altered. Endogenous 
ATG13 and ATG16L1 formed foci near damaged mitochondria 
following mitophagy stimulation in WT HeLa cells. However, 
under the same conditions, IRES-based overexpression of the 
BCAS3-C16orf70 complex resulted in severely decreased foci 
formation of both proteins (Figure 10A and 10B). This inhibi-
tory effect is dependent on BCAS3 phosphoinositide binding
Figure 9. Loss of the BCAS3-C16orf70 complex does not affect overall mitochondrial degradation in response to mitophagy. (A) WT and BCAS3-/-C16orf70-/- DKO 
clones #1-1-7 and #1-1-17 HCT116 cells stably expressing YFP-PRKN and mt-Keima were treated with DMSO or antimycin A and oligomycin (AO) for 9 h and then 
analyzed by FACS. Representative FACS data with the percentage of cells exhibiting lysosomal mt-Keima signals are shown. (B) Quantification of the FACS-based 
mitophagy in (A). Each dot represents the mean value and error bars represent mean ± s.d. in three independent experiments. Statistical differences were 
determined by student’s t-test (n.s.: not significant).
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Figure 10. Overexpression of the BCAS3-C16orf70 complex affects recruitment of core autophagy proteins to the phagophore assembly site. (A-D) HeLa cells stably 
expressing PRKN alone (upper panel) or with IRES-based overexpression of C16orf70-3HA/BCAS3 (C16-3HA/BCAS3), WT (middle panel), or R401A (lower panel) were 
treated with valinomycin for 3 h and then immunostained with the indicated antibodies. Images are displayed as z-stacked confocal slices. Bars: 20 µm. (E) The 
relative foci areas for endogenous ATG13, WIPI2, ATG16L1 and MAP1LC3B in cells shown in (A-D) were quantified. Each dot represents the mean value determined 
from >100 cells and error bars represent mean ± s.d. in two (for DMSO) and three (for valinomycin) independent experiments. Statistical differences were determined 
by student’s t-test (n.s.: not significant; **P < 0.01). (F) HeLa cells stably expressing PRKN and 3FLAG-ULK1 with or without IRES-based overexpression of C16orf70- 
3HA/BCAS3 (C16-3HA/BCAS3), WT, or R401A were treated with DMSO or valinomycin for 3 h. The cell lysates were co-immunoprecipitated with an anti-FLAG 
antibody and 30% of the input and bound fractions were analyzed by western blotting. Orange arrowheads denote ubiquitinated TOMM20.
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since overexpression of the BCAS3R401A mutant with C16orf70 
did not affect the recruitment of either ATG13 or ATG16L1 to 
the phagophore assembly site (Figure 10A and 10B). In contrast, 
overexpression of the BCAS3-C16orf70 complex had no effect 
on the recruitment of the phosphoinositide-binding protein 
WIPI2 or MAP1LC3B-labeled autophagosome formation 
(Figure 10C – 10E). Of note, the composition of the ULK com-
plex was not altered by overexpression of the BCAS3-C16orf70 
complex under basal or mitophagy-inducing conditions (Figure 
10F). A number of studies have reported that ZFYVE1 over-
expression impedes phosphoinositide-binding protein recruit-
ment by concealing phosphoinositides on the phagophore 
assembly site [7,66]. Therefore we compared the degree of endo-
genous ATG13, ATG16L1, WIPI2 and MAP1LC3B recruitment 
in cells in which the BCAS3-C16orf70 complex was overex-
pressed with cells in which ZFYVE1 and WIPI1 were overex-
pressed. The recruitment of ATG13 and ATG16L1 was reduced 
following ZFYVE1 overexpression as was the association of 
WIPI2 with the phagophore assembly site (Fig. S7A – S7C), 
whereas MAP1LC3B-labeled autophagosomes accumulated 
(Fig. S7D). WIPI1 overexpression, on the other hand, inhibited 
ATG13 foci formation, but had no effect on the recruitment of 
ATG16L1, WIPI2 or MAP1LC3B during mitophagy (Fig. S7A – 
S7E). WIPI2 recruitment was only inhibited when ZFYVE1 was 
overexpressed, suggesting that the BCAS3-C16orf70 complex 
does not simply compete with WIPI proteins for PtdIns3P on 
the phagophore assembly site.
The BCAS3-C16orf70 complex binds PtdIns3P in vitro
Structural modeling (Figure 7) and cellular analyses (Figure 8) 
strongly suggest that the BCAS3-C16orf70 complex is 
recruited to phagophores via BCAS3 phosphoinositide- 
binding. To test this, we performed an in vitro membrane
flotation assay using PtdIns3P-containing liposomes. GFP- 
BCAS3-His and GFP-C16orf70-His were purified from 
HEK293T cells along with the control proteins, GFP-His 
and GFP-WIPI1-His (Figure 11A). Liposomes composed of 
phosphatidylcholine (PC) and phosphatidylethanolamine 
(PE) with or without PtdIns3P or PtdIns(3,5)P2 were incu-
bated with the purified proteins, and then centrifuged using 
an OptiPrep step gradient (Figure 11B). Consistent with 
a previous report [63], WIPI1 strongly bound the PtdIns3P- 
and PtdIns(3,5)P2-containing liposomes, whereas GFP alone 
did not (Figure 11C). Furthermore, WT BCAS3 was found in 
the liposome-containing fraction (T, top fraction) when it 
contained PtdIns3P or PtdIns(3,5)P2 (Figure 11C). 
BCAS3R401, which is not recruited to the phagophore assem-
bly site in response to PRKN-mediated mitophagy (Figure 
8B), interacted with the high percentage (15%) PtdIns3P 
liposomes similar to that of WT BCAS3. However, in the 
presence of reduced (5%) PtdIns3P, BCAS3R401 more readily 
dissociated from the liposome than WT BCAS3 (Figure 11D). 
These results indicate that BCAS3-C16orf70 complex interac-
tions with PtdIns3P-labeled membranes are partially depen-
dent on the phosphoinositide binding pocket in the BCAS3 
WD40 repeat domain.
Discussion
The transfer of intracellular materials to lysosomes requires de 
novo autophagic membrane synthesis. In mammals, the bio-
genesis of autophagosome formation is complicated, requiring 
a number of accessory and/or regulatory components. In this 
study, using PRKN-mediated mitophagy as an autophagy- 
inducing model and MS-based analyses, we identified 
human BCAS3 and C16orf70 as novel proteins that associate 
with the phagophore assembly site.
Figure 11. The BCAS3-C16orf70 complex binds to PtdIns3P in vitro. (A) CBB staining of purified GFP-His, GFP-WIPI1-His, GFP-BCAS3-His/GFP-C16orf70-His and GFP- 
BCAS3R401A-His/GFP-C16orf70-His. (B) Schematic diagram of the liposome flotation assay. After incubating the liposome solution with purified proteins, OptiPrep was 
added to a final concentration of 35% and then 30% OptiPrep and buffer were sequentially layered on top. After centrifugation, the Bottom (B), Middle (M) and Top 
(T) fractions are collected and analyzed by western blotting. (C) Flotation assays using the purified proteins and liposomes containing the indicated phosphoinosi-
tides were performed. GFP-His and GFP-WIPI1-His were detected with an anti-GFP antibody, and GFP-BCAS3-His was detected with an anti-BCAS3 antibody. (D) 
Flotation assays using liposomes with various concentrations of PtdIns3P were performed. GFP-BCAS3-His was detected with an anti-BCAS3 antibody.
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BCAS3 and C16orf70 have no known counterparts in yeast 
(e.g. Saccharomyces cerevisiae). Our homology predictions, 
which considered secondary structure and the presence of 
disordered regions in the WD40 repeat domain, however, 
suggested structural similarities between human BCAS3 and 
yeast PROPPIN family proteins. Subsequent structural mod-
eling revealed the presence of two phosphoinositide-binding 
pockets in the human BCAS3 WD40 repeat domain. 
Although the FRRG motif, which is diagnostic of WD40 
repeat domains in PROPPINs, is not conserved in BCAS3, 
structural analyses have shown that the second and third 
arginine in the PROPPIN FRRG motif correspond to two 
different phosphoinositide-binding pockets [63,64]. Our 
mutational analysis showed that the site 2 pocket, a part of 
which includes the arginine in the LHRG motif (i.e. R401 in 
human BCAS3), is critical for association with phagophores. 
We also showed that BCAS3 recruitment to the phagophore 
assembly site is dependent on the insertions in two of the 
propeller blades structures, a finding that is consistent with 
previous results showing that insertions in the WD40 repeat 
domain support membrane associations [63,64]. In addition, 
although BCAS3 localizes to the cytosol under basal growing 
conditions, no BCAS3 associations with endosomes or Golgi 
membranes, which are typically rich in phosphoinositides, 
were observed. Therefore, taken together, the evidence 
strongly suggests that BCAS3 is a PROPPIN subtype specific 
for the autophagic membrane.
To clarify the function of BCAS3 and C16orf70 in 
autophagy, we knocked out each individually and in 
tandem. The absence of mitophagy defects in 
BCAS3-/-C16orf70-/- cells was not unexpected as all 
known autophagy-specific phosphoinositide-binding 
proteins are thought to more or less function coopera-
tively in elongation of the phagophore. siRNA-mediated 
knockdown of ZFYVE1 likewise generated no obvious 
autophagy defects [7]. Alfy, a 400 kDa protein with both 
WD40 and FYVE domains that directly interacts with 
ATG5, is also not required for starvation-induced auto-
phagy [67]. Furthermore, autophagy defects in single 
wdr45 KO mice neurons [68] are much milder than 
those in either atg5 [69] or atg7 KOs [70]. On the 
other hand, we found that overexpressing an active 
BCAS3-C16orf70 complex inhibited the recruitment of 
ATG13 and ATG16L1 without affecting the association 
of WIPI2 with the phagophore assembly site. Therefore, 
the inhibitory effect generated by BCAS3-C16orf70 
overexpression likely does not arise from simple com-
petition with endogenous WIPI proteins, which differs 
from that of ZFYVE1 overexpression (Figure 10E and 
Fig. S7E). The BCAS3-C16orf70 complex may thus fine- 
tune autophagy activity by either regulating the associa-
tion of other core proteins with the phagophore assem-
bly site or functioning cooperatively with the core 
proteins.
During the preparation of this manuscript, Yamada et al. 
identified KinkyA and DDB_G0272949, homologs of mam-
malian C16orf70 and BCAS3, respectively, as genes 
involved in spore formation in Dictyostelium, a species of 
soil-dwelling amoeba [71]. Although the phenotypes are
much weaker than those observed following gene deletion 
of core autophagy proteins such as atg5 or atg7, the study 
showed that autophagic activity (monitored by the effi-
ciency of Atg8 delivery to lysosomes) is impaired following 
deletion of either KinkyA or DDB_G0272949 in 
Dictyostelium.
Although the molecular functions of the mammalian 
BCAS3-C16orf70 complex remain enigmatic, mouse 
BCAS3 has been proposed to function in angiogenesis 
[42,72]. While we did not observe the BCAS3- 
microtubule associations suggested by the previous report, 
it will be interesting in the future to determine if any 
autophagic defects are observed in animals following 
depletion of BCAS3 (or C16orf70). Similarly, it would be 
worthwhile to investigate any potential relationships 
between the BCAS3-C16orf70 complex and autophagic 




HeLa [32], HEK293 [32], and HEK293T (ATCC, CRL-3216) 
cell lines were cultured in Dulbecco’s modified Eagle’s med-
ium (Sigma-Aldrich, D5796; DMEM) supplemented with 10% 
(v:v) fetal bovine serum (Biowest, S1820; FBS), 1× sodium 
pyruvate (Gibco, 11360–070), 1× nonessential amino acids 
(Gibco, 11140–050; NEAA), and 1× Penicillin-Streptomycin- 
Glutamine (Gibco, 10378–016; PSG) or 1× GlutaMax (Gibco, 
35050–061). HCT116 cell lines were cultured in McCoy’s 5A 
medium (Gibco, 16600108) supplemented with 10% (v:v) FBS, 
NEAA, and PSG. All cells were incubated at 37°C in a 5% CO2 
incubator.
To induce mitophagy, the mitochondrial membrane poten-
tial was dissipated with 10 µM valinomycin (Sigma-Aldrich, 
V0627). To induce mitophagy without lysosomal neutraliza-
tion, cells were treated with a mixture of 10 µM oligomycin 
(Calbiochem, 495455) and 4 µM antimycin A (Sigma-Aldrich, 
A8674). To induce amino-acid starvation, cells were washed 
with phosphate-buffered saline (PBS; 10 mM phosphate, pH 
7.4, 137 mM NaCl, 2.7 mM KCl) and incubated with DMEM 
without amino acids (Wako, 048–33575) for 1 h. Wortmannin 
(Sigma-Aldrich, W1628) was used at a final concentration of 
100 nM to inhibit PtdIns3P synthesis. A/C Heterodimerizer 
(Clonetech, AP21967) was used at a final concentration of 
500 nM. Q-VD-OPh (AdipoGen Life Sciences, AG-CP3-0006- 
M005) was used at a final concentration of 10 µM to prevent 
apoptosis.
Plasmid construction and mutagenesis
For gene cloning, genes of interest were amplified from HeLa 
and HCT116 cell cDNA libraries and inserted into pTOPO- 
vector using a TOPO TA cloning kit (Thermo Fisher 
Scientific, 45–0030).
For 3FLAG and 3HA tags, the genes were amplified from 
pTOPO-plasmids or plasmids purchased from Addgene 
(36456 and 24302; deposited by Noboru Mizushima, 19922;
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deposited by Yue Xiong, 11185; deposited by William Sellers, 
70446; deposited by Dominic Esposito, 19723; deposited by 
Channing Der, 38318; deposited by Quan Lu, 11771; depos-
ited by Sankar Ghosh, 20648; deposited by William Hahn and 
Jean Zhao) or RIKEN BioResource Research Center 
(IRAL043P19, IRAL002B07, IRAL012J06, IRAK026K16, 
ARiS122O22) using a Phusion High-Fidelity PCR system 
(Thermo Fisher Scientific, F-530L). Products were inserted 
using the Gibson Assembly system (New England Biolabs, 
E2611S) or SLiCE [73] into the BamHI and EcoRI sites of 
vectors containing 3FLAG-TEV (TEV protease cleavage site: 
ENLYFQS), 3HA-TEV, TEV-3FLAG, or TEV-3HA coding 
sequences [32]. To express hAG or Ash fusion proteins for 
the fluoppi assay, genes encoding BCAS3 and C16orf70 were 
inserted into the BamHI and NotI sites of phAG-MCL 
(Medical & Biological Laboratories, AM-8011M) and pHA- 
Ash-MCL [32]. To construct BCAS3-2FKBP-HA for the FRB- 
FKBP dimerization assay, the BCAS3 coding sequence was 
inserted into the EcoRI and XbaI sites of the PINK1Δ110-YFP
-FKBP plasmid [48], which has two tandem FKBP followed by 
a single HA-tag; insertion of the BCAS3 coding sequence 
between the EcoRI and XbaI sites replaced the PINK1Δ110- 
YFP sequence. The plasmid expressing FRB-FIS1 (i.e. the 
mitochondrial transmembrane domain of FIS1 fused to 
FRB) was a kind gift from Dr. Richard J. Youle. Point muta-
tions or partial deletions were introduced either by primer- 
based direct PCR mutagenesis or by 2-step PCR followed by 
ligation using a DNA Ligation Kit (TaKaRa Bio, 6023). All the 
plasmids used in this study are listed in Table 1.
Plasmid transfection
For transient expression, plasmid complexes with FuGENE6 
(Promega, E269A) in OPTI-MEM (Thermo Fisher Scientific, 
31985–070) were generated according to the manufacture’s 
instruction and then transfected into cells for 24 h or more. 
For protein purification from HEK293T cells, polyethyleni-
mine (Polysciences, 23966; PEI) was used as the transfection
Table 1. Plasmid DNAs used in this study.
# Plasmid DNA SOURCE
1 pMXs-puro retroviral vector Cell Biolabs, RTV-012
2 pBABE-puro retroviral vector Addgene, 1764 (Depositing Labs: Hartmut Land, Jay Morgenstern, Bob Weinberg)
3 pcDNA3.1(+) Invitrogen, V79020
4 pMXs-puro_YFP Yamano et al. 2020
5 pMXs-puro_3FLAG-TEV Yamano et al. 2020
6 pMXs-puro_3HA-TEV Yamano et al. 2020
7 pMXs-puro_TEV-3FLAG Yamano et al. 2020
8 pMXs-puro_TEV-3HA Yamano et al. 2020
9 pBABE-puro_3FLAG-TEV Yamano et al. 2020
10 pBABE-puro_3HA-TEV Yamano et al. 2020
11 pBABE-puro_TEV-3FLAG Yamano et al. 2020
12 pBABE-puro_TEV-3HA Yamano et al. 2020
13 pcDNA3.1(+)_3FLAG-TEV Yamano et al. 2020
14 pcDNA3.1(+)_3HA-TEV Yamano et al. 2020
15 pcDNA3.1(+)_TEV-3FLAG Yamano et al. 2020
16 pcDNA3.1(+)_TEV-3HA Yamano et al. 2020
17 pAsh-MCL Medical & Biological Laboratories, AM-8011M
18 pHA-Ash-MCL Yamano et al. 2020
19 phAG-MCL Medical & Biological Laboratories, AM-8011M
20 pUMVC (Gag-Pol) Kindly gifted from Dr. R.Youle Lab.
21 pCMV-VSV-G (VSV-G) Kindly gifted from Dr. R.Youle Lab.
22 pCHAC/EYFP-MAP1LC3B-IRES-MCS2 Yamano et al. 2014
23 FRB-FIS1 Lazarou et al. 2012
24 pBMNz-YFP-PRKN Lazarou et al. 2015
25 pMXs-puro_3FLAG-ZFYVE1 This study
26 pMXs-puro_3FLAG-WIPI1 This study
27 pMXs-puro_3HA-ZFYVE1 This study
28 pMXs-puro_3HA-WIPI1 This study
29 pcDNA3.1(+)_3HA-ZFYVE1 This study
30 pcDNA3.1(+)_3HA-WIPI1 This study
31 pMXs-puro_GST-PRKN This study
32 pMXs-puro_HA-PRKN Matsuda et al. 2010
33 pMXs-puro_3FLAG-BCAS3 This study; gene cloned from cDNA library
34 pMXs-puro_BCAS3-3FLAG This study
35 pMXs-puro_3FLAG-C16orf70 This study; gene cloned from cDNA library
36 pMXs-puro_C16orf70-3FLAG This study
37 pMXs-puro_3HA-BCAS3 This study
38 pMXs-puro_C16orf70-3FLAG This study
39 pMXs-puro_3FLAG-ATG2A This study; gene cloned from pEGFP-C1-hAtg2A (Addgene, 36456; Depositing Lab: Noboru Mizushima)
40 pMXs-puro_3FLAG-ATG2AΔC This study
41 pMXs-puro_3FLAG-CFAP298 This study; gene cloned from cDNA library
42 pMXs-puro_3FLAG-CUL4B This study; gene cloned from pcDNA3-myc3-CUL4B (Addgene, 19922; Depositing Lab: Yue Xiong)
43 pMXs-puro_3FLAG-DYNLL1 This study; gene cloned from cDNA library
44 pMXs-puro_3FLAG-GGA3 This study; gene cloned from 1574 pSG5L Flag HA GGA3 (Addgene, 11185; Depositing Lab: William Sellers)
45 pMXs-puro_3FLAG-PEBP1 This study; gene cloned from R777-E162 Hs.PEBP1-nostop (Addgene, 70446; Depositing Lab: Dominic Esposito)
46 pMXs-puro_3FLAG-RALA This study; gene cloned from pBabe puro RalA (short) wt (Addgene, 19723; Depositing Lab: Channing Der)
47 pMXs-puro_3FLAG-TRAPPC2 This study; gene cloned from cDNA library
48 pMXs-puro_3FLAG-TSG101 This study; gene cloned from pEF6.mCherry-TSG101 (Addgene, 38318; Depositing Lab: Quan Lu)
(Continued )
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Table 1. (Continued). 
# Plasmid DNA SOURCE
49 pMXs-puro_3FLAG-SORBS3 This study; gene cloned from cDNA library
50 pMXs-puro_3FLAG-EHMT2 This study; gene cloned from cDNA library
51 pMXs-puro_3FLAG-OCIAD2 This study; gene cloned from cDNA library
52 pMXs-puro_3FLAG-PDCD10 This study; gene cloned from cDNA library
53 pMXs-puro_PDCP10-3FLAG This study
54 pMXs-puro_3FLAG-GSTK1 This study; gene cloned from cDNA library
55 pMXs-puro_GSTK1-3FLAG This study
56 pMXs-puro_3FLAG-MmCHMP5 This study; gene cloned from pCINeo-mCHMP5 (Addgene, 11771; Depositing Lab: Sankar Ghosh)
57 pMXs-puro_MmCHMP5-3FLAG This study
58 pMXs-puro_3FLAG-MYL6B This study; gene cloned from cDNA library
59 pMXs-puro_MYL6B-3FLAG This study
60 pMXs-puro_3FLAG-TRAPPC2L This study; gene cloned from cDNA library
61 pMXs-puro_TRAPPC2L-3FLAG This study
62 pMXs-puro_3FLAG-RAB24 This study; gene cloned from cDNA library
63 pMXs-puro_VPS4B-3FLAG This study; gene cloned from cDNA library
64 pMXs-puro_3FLAG-VPS4B This study
65 pMXs-puro_3FLAG-MTMR6 This study; gene cloned from cDNA library
66 pMXs-puro_MTMR6-3FLAG This study
67 pMXs-puro_3FLAG-EI24 This study; gene cloned from cDNA library
68 pMXs-puro_EI24-3FLAG This study
69 pMXs-puro_3FLAG-SAR1B This study; gene cloned from cDNA library
70 pMXs-puro_SAR1B-3FLAG This study
71 pMXs-puro_3FLAG-CSTB This study; gene cloned from cDNA library
72 pMXs-puro_CSTB-3FLAG This study
73 pMXs-puro_3FLAG-EDC4 This study; gene cloned from cDNA library
74 pMXs-puro_EDC4-3FLAG This study
75 pMXs-puro_3FLAG-OPTN Yamano et al. 2020
76 pMXs-puro_3FLAG-SNX3 This study; gene cloned from cDNA library
77 pMXs-puro_SNX3-3FLAG This study
78 pMXs-puro_3FLAG-RIPK1 This study; gene cloned from cDNA library
79 pMXs-puro_RIPK1-3FLAG This study
80 pMXs-puro_3FLAG-COASY This study; gene cloned from cDNA library
81 pMXs-puro_COASY-3FLAG This study
82 pMXs-puro_3FLAG-NMT1 This study; gene cloned from cDNA library
83 pMXs-puro_NMT1-3FLAG This study
84 pMXs-puro_3FLAG-RAB1B This study; gene cloned from cDNA library
85 pMXs-puro_3FLAG-EHD3 This study; gene cloned from IRAL043P19 (RIKEN BioResource Research Center)
86 pMXs-puro_3FLAG-HGH1 This study; gene cloned from IRAL002B07 (RIKEN BioResource Research Center)
87 pMXs-puro_HGH1-3FLAG This study
88 pMXs-puro_3FLAG-YBX3 This study; gene cloned from IRAL012J06 (RIKEN BioResource Research Center)
89 pMXs-puro_YBX3-3FLAG This study
90 pMXs-puro_3FLAG-HDHD5 This study; gene cloned from IRAK026K16 (RIKEN BioResource Research Center)
91 pMXs-puro_HDHD5-3FLAG This study
92 pMXs-puro_3FLAG-WHAMM This study; gene cloned from ARiS122O22 (RIKEN BioResource Research Center)
93 pMXs-puro_WHAMM-3FLAG This study
94 pMXs-puro_3FLAG-RAB1A This study; gene cloned from cDNA library
95 pMXs-puro_3FLAG-MmATG16L1 This study; gene cloned from p3xFLAG-CMV10-mApg16L (Addgene, 24302; Depositing Lab: Noboru Mizushima)
96 pMXs-puro_3FLAG-HYPK This study; gene cloned from cDNA library
97 pMXs-puro_HYPK-3FLAG This study
98 pMXs-puro_3FLAG-TBK1 This study; gene cloned from pWZL Neo Myr Flag TBK1 (Addgene, 20648; Depositing Labs: William Hahn, Jean 
Zhao)
99 pMXs-puro_3HA-BCAS3H350A This study
100 pMXs-puro_3HA-BCAS3D370A This study
101 pMXs-puro_3HA-BCAS3L372A This study
102 pMXs-puro_3HA-BCAS3H377A This study
103 pMXs-puro_3HA-BCAS3H400A This study
104 pMXs-puro_3HA-BCAS3R401A This study
105 pMXs-puro_3HA-BCAS3R426A This study
106 pMXs-puro_3HA-BCAS3T428A This study
107 pMXs-puro_3HA-BCAS3H430A This study
108 pMXs-puro_3HA-BCAS3 Δ254-312 This study
109 pMXs-puro_3HA-BCAS3 Δ437–560 This study
110 pcDNA3.1(+)_C16orf70-3HA This study
111 pcDNA3.1(+)_C16orf70-3FLAG This study
112 pcDNA3.1(+)_3HA-BCAS3 This study
113 pcDNA3.1(+)_3HA-BCAS3(1–471) This study
114 pcDNA3.1(+)_3HA-BCAS3(472–913) This study
115 pcDNA3.1(+)_3HA-BCAS3(553–913) This study




118 pcDNA3.1(+)_3HA-BCAS3(553–913 Δ680- 
719)
This study
119 pcDNA3.1(+)_3HA-BCAS3(645–913 Δ680- 
719)
This study
120 pMRX-IP_GFP-mULK1 Kindly gifted from Dr. Mizushima Lab.
121 pMXs-puro_GFP-mZFYVE1 Kindly gifted from Dr. Mizushima Lab.
122 pMXs-puro_GFP-WIPI1 Kindly gifted from Dr. Mizushima Lab.
(Continued )
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reagent. For HEK293T cells seeded in one 10-cm dish, 
10–15 µg of plasmids were mixed with PEI at a ratio of 1:8 
in OPTI-MEM and then transfected into cells for 48 h.
For stable expression, retroviral plasmids were cotrans-
fected with Gag-pol and VSV-G plasmids into HEK293T 
cells grown in a 6-well plate using Lipofectamine LTX 
(Thermo Fisher Scientific, 15338100). After 12 h of transfec-
tion, the culture medium was replaced with fresh medium 
supplemented with HEPES (Gibco, 15630–080) and the cells 
were cultivated for another 24 h. Supernatants were filtered 
and infected into target cells using 8 µg/ml polybrene (Sigma- 
Aldrich, H9268). After infection for 24 h, the media was 
replaced with fresh media.
RNA interference
siRNAs for a non-target control (Thermo Fisher Scientific, 
D-001206-13-20; siGENOME Control siRNApool) or PINK1 
[74] were transfected into cells at a final concentration of 
10 nM using Lipofectamine RNAi MAX (Thermo Fisher
Scientific, 13778150). Cells were analyzed 48 h after 
transfection.
Immunofluorescence microscopy
Cells grown on 35-mm glass bottom dishes were fixed with 
4% paraformaldehyde (Wako, 163–20145; PFA) in PBS for 
15 min at room temperature. Cells were then permeabilized 
with 0.15% (v:v) Triton X-100 (MP Biomedicals, 807426) or 
50 µg/ml digitonin (Wako, 043–21371; for observing 
MAP1LC3B) for 18 min at room temperature, blocked with 
0.1% (w:v) gelatin (Sigma-Aldrich, G9391) in PBS for 30 min, 
and incubated with primary antibodies in 0.1% gelatin for 2 h 
at room temperature. After washing with PBS containing 
polyoxyethylene sorbitan monolaurate (nacalai tesque, 
35624–02; Tween20) (PBS-T), cells were incubated with sec-
ondary antibodies conjugated to Alexa Fluor for 1 h. For 
primary antibodies, anti-FLAG/DDDDK (Medical & 
Biological Laboratories, M185-3L), anti-FLAG/DDDDK 
(Medical & Biological Laboratories, PM020), anti-TOMM20 
(Santa Cruz Biotechnology, sc-17764), anti-TOMM20 (Santa
Table 1. (Continued). 
# Plasmid DNA SOURCE
123 pHA-Ash_C16orf70 This study
124 phAG-BCAS3 This study
125 pC4M-F2E-3HA-BCAS3-2FKBP-HA This study
126 phAG-BCAS3(1–644) This study
127 phAG-BCAS3(645–913) This study
128 phAG-BCAS3(1–471) This study
129 phAG-BCAS3(472–913) This study
130 phAG-BCAS3(553–913) This study
131 phAG-BCAS3 Δ472–559 This study
132 phAG-BCAS3 Δ560–599 This study
133 phAG-BCAS3 Δ600–639 This study
134 phAG-BCAS3 Δ640–679 This study
135 phAG-BCAS3 Δ680-719 This study
136 phAG-BCAS3 Δ720–759 This study
137 phAG-BCAS3 Δ760–799 This study
138 phAG-BCAS3 Δ800–839 This study
139 phAG-BCAS3 Δ840–879 This study
140 phAG-BCAS3 Δ880–913 This study
141 phAG-BCAS3(472–913 Δ680-719) This study
142 phAG-BCAS3(553–913 Δ680-719) This study
143 phAG-BCAS3(645–913 Δ680-719) This study
144 phAG-BCAS3H350A This study
145 phAG-BCAS3D370A This study
146 phAG-BCAS3L372A This study
147 phAG-BCAS3H377A This study
148 phAG-BCAS3H400A This study
149 phAG-BCAS3R401A This study
150 phAG-BCAS3R426A This study
151 phAG-BCAS3T428A This study
152 phAG-BCAS3H430A This study
153 phAG-BCAS3 Δ254-312 This study
154 phAG-BCAS3 Δ437–560 This study
155 pBABE-puro_Untag-PRKN Yamano et al. 2020
156 pCHAC MCS1-IRES-MCS2 Allele Biotechnology and Pharmaceuticals, ABP-PVL-BICISIRES
157 pCHAC_C16orf70-3HA-IRES-MCS2 This study
158 pCHAC_C16orf70-3HA-IRES-BCAS3 This study
159 pCHAC_C16orf70-3HA-IRES-BCAS3R401A This study
160 pRetroQ-mt-Keima Kindly gifted from Dr. Youle Lab.
161 pMXs-puro_3FLAG-mULK1 This study
162 pET21a vector Novagen, 69740
163 pET21a_BCAS3(645-913)-6×His This study
164 pT7-7_GFP-His Kindly gifted from Dr. Iwai Lab.
165 pcDNA3.1(+)_GFP-6xHis This study
166 pcDNA3.1(+)_GFP-WIPI1-6×His This study
167 pcDNA3.1(+)_GFP-BCAS3-6×His This study
168 pcDNA3.1(+)_GFP-BCAS3R401A-6×His This study
169 pcDNA3.1(+)_GFP-C16orf70-6×His This study
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Cruz Biotechnology, sc-11415), anti-BCAS3 (this study), anti- 
HA (Medical & Biological Laboratories, M180-3), anti-HA 
(Roche, 11867423001), anti-PRKN (Sigma-Aldrich, 
MAB5512), anti-WIPI2 (Sigma-Aldrich, SAB4200400), anti- 
ATG13 (Cell Signaling Technologies, 13468), anti-ATG16L1 
(Medical & Biological Laboratories, PM040), anti-mtDNA 
(PROGEN Biotechnik, AC-30-10) and anti-MAP1LC3 
(Medical & Biological Laboratories, PM036) were used. For 
secondary antibodies, Alexa Fluor 488-, 568-, or 647- 
conjugated goat anti-mouse or anti-rabbit IgG antibodies 
(Life Technologies, A11034, A11036, A21245, A11029, 
A11031, A21236) were used. 4ʹ,6-diamidino-2-phenylindole 
(Invitrogen, D3571; DAPI) was used for nuclear staining. 
The images were acquired using an inverted confocal micro-
scope (Carl Zeiss; LSM780) with a Plan-Apochromat 63×/1.4 
oil lens. DAPI fluorescence was obtained using excitation with 
a 405 nm laser, whereas fluorescence for YFP, GFP and hAG 
was obtained using excitation with a 488 nm laser. Other 
fluorescence signals were obtained using filter sets of the 
appropriate wavelengths. For image analysis, ZEN microscope 
software (Carl Zeiss) and Photoshop (Adobe) were used. 
Z-stack images were constructed from 7–10 images captured 
in multiple focal planes with a step interval of 1.0 µm.
A TCS SP8 laser scanning confocal microscope (Leica 
Microsystems) with an HC PLAPO CS2 63×/1.4 oil lens was 
also used for Figure 5I and 5J. Multiple (34–37) confocal 
images (pixel size: 45 nm × 45 nm) with a 130 nm z-step 
size were taken and Huygens Professional deconvolution per-
formed followed by maximum projection.
Western blotting and CBB staining
To briefly confirm protein expression, cells grown in a 6-well 
plate were washed with PBS and lysed with the appropriate 
amount of SDS-PAGE sample buffer supplemented with 
1,4-dithiothreitol (Roche, 10708984001; DTT). Lysates were 
boiled at 98°C for 5 min and genomic DNA shredded by 
sonication. To obtain the total cell lysate, cells grown in 
a 6-well plate or a 6-cm dish were washed with PBS, collected 
and solubilized with TNE-N+ buffer (20 mM Tris–HCl, pH 
8.0, 150 mM NaCl, 1 mM EDTA, 1% [v:v] Nonidet® P40 
[nacalai tesque, 25223–75; NP-40] and a protease inhibitor 
cocktail [Roche, 11873580001]). After removing insoluble 
debris by centrifugation at 12,000 × g, 4°C for 15 min, the 
protein concentration of the supernatants was measured using 
a Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, 
23227). The supernatants were mixed with SDS-PAGE sample 
buffer and boiled at 98°C for 5 min.
Proteins were separated on 4–12% or 12% Bis-Tris SDS– 
PAGE gels (Invitrogen; NuPAGE) in MES or MOPS buffer, 
and then transferred to PVDF membranes (Merck Millipore, 
IPVH00010). Membranes were blocked with 2.5% (w:v) skim- 
milk (BD Biosciences, 232100) in tris buffered saline with 
Tween20 (TBS-T) for 30 min, then incubated with primary 
antibodies for 1.5–2 h, and secondary antibodies for 1 h at 
room temperature. For primary antibodies, anti-FLAG 
/DDDDK (Medical & Biological Laboratories, M185-3L), anti-
FLAG/DDDDK (Medical & Biological Laboratories, PM020), 
anti-TOMM20 (Santa Cruz Biotechnology, sc-11415), anti- 
HA (Medical & Biological Laboratories, M180-3), anti-HA 
(Roche, 11867423001), anti-GFP (abcam, ab6556), anti- 
MFN2 (abcam, ab56889), anti-MT-CO2 (abcam, ab110258), 
anti-PDHA1 (abcam, ab110334), anti-BCAS3 (this study), 
anti-ATG13 (Cell Signaling Technology, 13468), anti- 
RB1CC1 (Cell Signaling Technology, 12436S; D10D11), anti- 
ATG16L (Medical & Biological Laboratories, PM040), anti- 
MAP1LC3B (Sigma-Aldrich, L7453), anti-WIPI2 (Sigma- 
Aldrich, SAB4200400), anti-azami-green (Medical & 
Biological Laboratories, PM011M), anti-ACTA1 (Merck 
Millipore, MAB1501R; C4) or anti-GAPDH (Merck 
Millipore, MAB374) antibodies were used. Secondary anti-
body detection was carried out using a BCIP-NBT Solution 
Kit for Alkaline Phosphatase Stain (nacalai tesque, 03937–60) 
with alkaline phosphatases conjugated to goat anti-mouse 
(Santa Cruz Biotechnology, sc-2008) or goat anti-rabbit IgG 
(Santa Cruz Biotechnology, sc-2007). Secondary antibody 
detection done with a Western Lightning Plus ECL 
(PerkinElmer, NEL105001EA) involved horseradish peroxi-
dase (HRP)-conjugated goat anti-mouse IgG (Promega, 
W402B), goat anti-rabbit IgG (Jackson Immuno Research 
Laboratories, 111–035-144), donkey anti-rat IgG (Jackson 
Immuno Research Laboratories, 712–035-153), or donkey 
anti-goat IgG (Santa Cruz Biotechnology, sc-2020). Proteins 
were detected in the linear range of detection using an 
ImageQuant LAS 4000 instrument (GE Healthcare Life 
Sciences).
For immunoblot-based detection of protein-protein inter-
actions, cells grown in a 6-well plate or 6-cm dish were 
washed with PBS, and solubilized on ice for 15 min in IP 
buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 0.5% [w:v] 
sodium deoxycholate [Sigma-Aldrich, D6750], 1% [v:v] Triton 
X-100, and a protease inhibitor cocktail, 10 µM MLN7243 
[Active Biochem, A-1384]). Unsolubilized debris was 
removed by centrifugation at 16,000 × g, 4°C for 10 min. 
A fraction of the supernatants were incubated with anti- 
DDDDK-tag mAb magnetic beads for 1.5–2 h at 4°C under 
gentle rotation; the remaining (30% against the bound frac-
tion) was collected as input. Beads were washed with IP buffer 
three times and bound proteins were eluted with SDS-PAGE 
sample buffer. The supernatant inputs were precipitated with 
trichloroacetic acid (Wako, 200–08085) and solubilized with 
SDS-PAGE sample buffer.
For Coomassie Brilliant Blue (CBB) staining, proteins were 
separated on 4–12% Bis-Tris SDS–PAGE gels in MES buffer, 
and gels were incubated in a destaining solution (30% metha-
nol, 10% acetic acid) for 10 min at room temperature. After 
four 10 min water washes, the proteins were detected using 
CBB Stain One (nakalai tesque, 04543–51).
LC-MS/MS-based identification of ZFYVE-1 or 
WIPI1-associated proteins
Cells stably expressing FLAG-tagged proteins grown in a 10- 
cm dish were treated with or without 10 µM valinomycin for
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3 h, and then treated with 0.1% PFA for 10 min at room 
temperature. After PFA fixation was quenched with 300 mM 
glycine, cells were washed with PBS, and solubilized on ice for 
10 min in RIPA buffer (50 mM Tris–HCl pH 7.5, 150 mM 
NaCl, 0.1% [w:v] SDS, 0.5% [w:v] sodium deoxycholate, 1% 
[v:v] Triton X-100, and a protease inhibitor cocktail). After 
centrifugation at 16,000 × g, 4°C for 10 min, the supernatants 
were incubated with anti-DDDDK-tag mAb magnetic beads 
(Medical & Biological Laboratories, M185-11) for 1.5 h at 4°C 
under gentle rotation. The beads were collected using 
a magnetic stand, washed three times with RIPA buffer, and 
then another three times with 50 mM ammonium bicarbo-
nate. Proteins bound to the beads were digested with a 200 ng 
trypsin/Lys-C mix (Promega, V5072) for 16 h at 37°C. The 
digests were acidified with trifluoroacetic acid (Wako, 
206–10731; TFA) and desalted using GL-Tip SDB (GL 
Sciences, 7820–11200). The eluates were evaporated in 
a SpeedVac concentrator and dissolved in 0.1% TFA.
LC-MS/MS analysis of the resultant peptides was per-
formed using an EASY-nLC 1200 UHPLC connected to a Q 
Exactive Plus mass spectrometer equipped with 
a nanoelectrospray ion source (Thermo Fisher Scientific). 
The peptides were separated on a 75-µm inner diameter × 
150-mm C18 reversed-phase column (Nikkyo Technos, 75- 
3-155) using a linear 4–28% acetonitrile (ACN) gradient for 
0–100 min followed by an increase to 80% ACN for 10 min. 
The mass spectrometer was operated in a data-dependent 
acquisition mode with a top 10 MS/MS method. MS1 spectra 
were measured at a resolution of 70,000, an automatic gain 
control (AGC) target of 1 × 106 and a mass range from 350 to 
1,500 m/z. HCD MS/MS spectra were acquired at a resolution 
of 17,500, an AGC target of 5 × 104, an isolation window of 
2.0 m/z, a maximum injection time of 60 ms and a normalized 
collision energy of 27. Dynamic exclusion was set to 10 s. Raw 
data were directly analyzed against the SwissProt database 
restricted to H. sapiens using Proteome Discoverer version 
2.2 (Thermo Fisher Scientific) with Mascot search engine 
version 2.5 (Matrix Science) used for identification and label- 
free precursor ion quantification. The search parameters were 
as follows: (i) trypsin as an enzyme with up to two missed 
cleavages; (ii) precursor mass tolerance of 10 ppm; (iii) frag-
ment mass tolerance of 0.02 Da; and (iv) acetylation of the 
protein N-terminus and oxidation of methionine as variable 
modifications. Peptides and proteins were filtered at a false 
discovery rate (FDR) of 1% using the percolator node and the 
protein FDR validator node, respectively. Normalization was 
performed such that the total sum of abundance values for 
each sample over all peptides was the same.
Generation of knockout (KO) cell lines
BCAS3-/- and C16orf70-/- HCT116 cell lines were established 
using a CRISPR-Cas9-based genome editing method with an 
antibiotic-selection strategy described previously [75]. The 
guide-RNAs (gRNA) targeted exon 2 in the BCAS3 gene (for 
line #1: ACTCCACCAGTACAACGACTGGG, for line #2:
AGAAGACCCAGTCGTTGTACTGG and for line #3: 
TGGAGTTGTGGTTCGCCCCCAGG) or exon 1 in the 
C16orf70 gene (for line #1: 
GTAGTGCCCGAACGCTCTCTGGG and for line #2: 
GGTAGTGCCCGAACGCTCTCTGG). The gRNAs were 
designed using an online CRISPR design tool: Guide Design 
Resources (https://zlab.bio/guide-design-resources). Three 
pairs of DNA oligonucleotides: BCAS3-ex2-1-CRISPR-F/R 
(5ʹ-TGT ATG AGA CCA CAC TCC ACC AGT ACA ACG 
ACT-3ʹ, 5ʹ-AAA CAG TCG TTG TAC TGG TGG AGT GTG 
GTC TCA-3ʹ), BCAS3-ex2-2-CRISPR-F/R (5ʹ-TGT ATG AGA 
CCA CAG AAG ACC CAG TCG TTG TAC-3ʹ, 5ʹ-AAA CGT 
ACA ACG ACT GGG TCT TCT GTG GTC TCA-3ʹ), and 
BCAS3-ex2-3-CRISPR-F/R (5ʹ-TGT ATG AGA CCA CTG 
GAG TTG TGG TTC GCC CCC-3ʹ, 5ʹ-AAA CGG GGG 
CGA ACC ACA ACT CCA GTG GTC TCA-3ʹ) for the 
BCAS3 KO, and two pairs of DNA oligonucleotides: 
C16orf70-ex1-1-CRISPR-F/R (5ʹ-TGT ATG AGA CCA CGT 
AGT GCC CGA ACG CTC TCT-3ʹ, 5ʹ-AAA CAG AGA GCG 
TTC GGG CAC TAC GTG GTC TCA −3ʹ), and C16orf70-ex1 
-2-CRISPR-F/R (5ʹ-TGT ATG AGA CCA CGG TAG TGC 
CCG AAC GCT CTC-3ʹ, 5ʹ-AAA CGA GAG CGT TCG GGC 
ACT ACC GTG GTC TCA-3ʹ) for the C16orf70 KO were 
annealed and inserted into a linearized pEF1-hspCas9-H1- 
gRNA vector (System Biosciences, CAS700A-1) according to 
the manufacturer’s instructions.
To construct donor plasmids, 500 bp sequences, which 
include 247 bp of the 5ʹ and 3ʹ of the gRNA targeting regions 
as homologous arms and a BamHI site in the middle instead of 
the gRNA sequence were synthesized in a pUC57-Amp vector 
(GENEWIZ). The neomycin-resistant gene (NeoR) and the 
hygromycin-resistant gene (HygroR), including the loxP sites 
along with the appropriate promoter and terminator [75] were 
inserted into the BamHI site of the pUC57-Amp plasmids. The 
resultant pEF1-hspCas9-H1-gRNA plasmids and pUC57-Amp 
donor plasmids containing NeoR or HygroR were transfected 
into HCT116 cells using FuGENE HD (Promega, E2311). After 
48 h transfection, cells were grown in McCoy’s 5A media con-
taining 700 µg/ml G418 (Sigma-Aldrich, G8168) and 100 µg/ml 
hygromycin B (Invitrogen, 10687–10). Single colonies were iso-
lated into a 24-well plate. To verify neomycin-resistant and 
hygromycin-resistant gene insertion, genomic DNA was 
extracted using a Microprep Kit Quick-gDNA (Zymo 
Research, D3021) and PCR amplified with primer pairs for 
BCAS3; BACS3-ex2-check-F2/R2 (5ʹ-TCC CAT CCC ATG 
ATC TGG TTC-3ʹ, 5ʹ-TCT GAA ATG TGC TTA CGT GAC 
AG-3ʹ), and for C16orf70; C16orf70-ex1-check-F3/R3 (5ʹ-CGG 
CAC GCC ACT TTT ACT G-3ʹ, 5ʹ-AGG CAT TTG GGG AGA 
GCA AG-3ʹ).
BCAS3-/-C16orf70-/- DKO cell lines were established 
as follows. NeoR and HygroR markers were removed 
from BCAS3-/- HCT116 (clone #1-24) using Cre 
Recombinase Gesicles (TaKaRa Bio, 631449). BCAS3-/- 
HCT116 (clone #1-24) cells grown in a 12-well plate 
were treated with polybrene and Cre Recombinase 
Gesicles and centrifuged at 1,200 × g for 30 min.
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Single colonies were then isolated, and elimination of 
the NeoR and HygroR markers was confirmed by PCR. 
CRISPR-Cas9-based genome editing with an antibiotic- 
selection strategy was likewise used to establish the 
BCAS3-/-C16orf70-/- HCT116 cell lines.
Preparation of recombinant BCAS3 for antibody 
production
To purify proteins from E.coli, the human BCAS3 gene (resi-
dues 645–913) was amplified and inserted into the EcoRI/ 
XhoI sites of a pET21a vector (Novagen, 69740), which intro-
duced a 6×His C-terminal tag. pET21a/BCAS3(645–913aa) 
was then introduced into BL21-CodonPlus(DE3)-RIL 
(Agilent Technologies, 230245). The transformants were cul-
tured in Terrific Broth media at 37°C until the logarithmic 
growth phase. Protein expression was induced with 1 mM 
Isopropylβ-D-1-thiogalactopyranoside (IPTG) for 3 h. The 
cells were collected by centrifugation, lysed with TBS buffer 
(50 mM Tris-HCl, pH 7.5, 120 mM NaCl, 50 µg/ml lysozyme 
(Wako, 122–02673), 1 µg/ml DNaseI (Worthington 
Biochemical Corporation, 26P9235), 1 mM DTT, 1 mM 
MgCl2, a protease inhibitor cocktail) and sonicated. After 
centrifugation at 8,000 × g, 4°C for 15 min, the pellet was 
resuspended with Triton X-100 buffer (50 mM Tris-HCl, pH 
7.5, 120 mM NaCl, 0.1% [v:v] Triton X-100). The insoluble 
fraction containing recombinant BCAS3 was collected by 
centrifugation at 8,000 × g, 4°C for 15 min and solubilized 
with urea buffer (50 mM Tris-HCl, pH 7.5, 120 mM NaCl, 
6 M urea [GE Healthcare Life Sciences, 17–1319-01]) and 
incubated with Ni-NTA agarose (QIAGEN, 30250) for 
30 min at 4°C under gentle rotation. The agarose was washed 
three times with urea buffer, and bound proteins were step- 
wise eluted with urea buffer containing 40, 80, and 200 mM 
imidazole. Recombinant His-tagged BCAS3 (residues 
645–913) was concentrated using an Amicon-Ultra-15 
(Merck Millipore, UFC901024), and imidazole was removed 
using PD midiTrap G-25 (GE Healthcare Life Sciences, 
28–9180-08). Anti-BCAS3 antiserum was acquired by immu-
nizing rabbits with the purified BCAS3(645–913aa)-6×His 
and the anti-BCAS3 antibody was purified using CNBr- 
activated sepharose 4B coupled to recombinant BCAS3(645– 
913aa) (Eurofins Genomics).
Preparation of recombinant proteins for liposome 
flotation assay
To generate purified recombinant GFP, Escherichia coli BL21- 
CodonPlus(DE3)-RIL (Agilent Technologies) cells harboring 
pT7-7/GFP-His (a kind gift from Dr. Kazuhiro Iwai, Kyoto 
university, Japan) were grown in LB medium supplemented 
with 100 µg/ml ampicillin and 25 µg/ml chloramphenicol at 
37°C. GFP-His was expressed at 23°C for 12 h by addition of 
500 µM IPTG. The bacterial cell pellets were wash with TBS 
(50 mM Tris-HCl, pH 7.5, 120 mM NaCl), resuspended in 
TBS supplemented with lysozyme and a protease inhibitor 
cocktail, and then stored at −20°C until used. The frozen 
cell suspension was thawed and sonicated, and insoluble pro-
teins were removed by centrifugation. The resultant
supernatant was incubated with equilibrated Ni-NTA agarose 
resin for 15 min at 4°C. The resin was washed with TBS 
containing 10 mM imidazole, and the bound proteins were 
eluted with TBS containing 200 mM imidazole. The buffer 
was exchanged by dialyzing against TBS containing 10% (v:v) 
glycerol.
Purified GFP-WIPI1-6× His, GFP-BCAS3-6× His, GFP- 
BCAS3R401A-6× His and GFP-C16orf70-6× His were similarly 
generated. Human WIPI1, BCAS3 (WT and R401A) and 
C16orf70 genes were amplified with primers that included 
nucleotides encoding a 6× His tag and then inserted into the 
XhoI site of the pcDNA3.1(+) vector. To generate the 
N-terminal tag, GFP was amplified and inserted into the 
BamHI/EcoRI site of the pcDNA3.1(+) constructs.
pcDNA3.1(+)/GFP-WIPI1-6×His, pcDNA3.1(+)/GFP- 
BCAS3-6×His, pcDNA3.1(+)/GFP-BCAS3R401A-6×His, and 
pcDNA3.1(+)/GFP-C16orf70-6×His were transfected into 
HEK293T cells using PEI. After 48 h transfection, cells were 
harvested from twelve 10-cm dishes, washed with PBS and 
lysed with lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 1% NP-40, 1 mM DTT, and a protease inhibitor cock-
tail) for 15 min on ice. After the insoluble proteins were 
removed by centrifugation at 12,000 × g, 4°C for 10 min, 
the supernatants were incubated with equilibrated Ni-NTA 
agarose for 1 h at 4°C under gentle rotation. The resins were 
washed with TBS containing 1 mM DTT and 20 mM imida-
zole, and the bound proteins were eluted with TBS containing 
500 mM imidazole. Eluted fractions were concentrated, and 
the buffer composition was gradually exchanged to TBS con-
taining 10% (v:v) glycerol using an Amicon-Ultra-15.
Liposome preparation and liposome flotation assay
To prepare liposomes, the following lipids were used: 1,2-dio-
leoyl-sn-glycero-3-phosphoethanolamine (Avanti Polar 
Lipids, 850725C; PE), 1-palmitoyl-2-oleoyl-sn-glycero 
-3-phosphocholine (Avanti Polar Lipids, 850457C; PC), 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine- 
N-(carboxyfluorescein) (Avanti Polar Lipids, 810332P; 
fluoPE), phosphatidylinositol 3-phosphate diC16 (Echelon 
Biosciences, P-3016; PtdIns3P), phosphatidylinositol 
3,5-bisphosphate diC16 (Echelon Biosciences, P-3516; 
PtdIns(3,5)P2). PC, PE, and fluoPE were dissolved in chloro-
form. PtdIns3P and PtdIns(3,5)P2 were dissolved in chloro-
form:methanol:water (1:2:0.8). Lipids were mixed in a glass 
tube in the following molar ratios: control liposomes – 70% 
PC, 28% PE, and 2% fluoPE; 5% PtdIns3P or PtdIns(3,5)P2- 
containing liposomes – 5% PtdIns3P or PtdIns(3,5)P2, 65% 
PC, 28% PE, and 2% fluoPE; 15% PtdIns3P or PtdIns(3,5)P2- 
containing liposomes – 15% PtdIns3P or PtdIns(3,5)P2, 55% 
PC, 28% PE, and 2% fluoPE. To make lipid films, the organic 
solvent in the lipid mixtures was removed using a vacuum 
rotary evaporator. Lipid films were re-hydrated in liposome 
buffer (20 mM HEPES-KOH, pH 7.5, 150 mM KCl) at 
a 1 mM lipid concentration. To obtain liposomes, the film 
suspension was subjected to vigorous vortexing, repeated 
freeze-thaw cycles, sonication, and finally extrusion through 
0.1 µm polycarbonate membranes (Avanti Polar Lipids, 
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610005–1EA). Each liposome solution was stored at 4°C
until used.
Prior to the liposome flotation assay, 1.5-ml micro-
centrifuge tubes (Eppendorf Himac Technologies, 
S308892A) were incubated with blocking buffer (5% 
skim-milk, 1% BSA) for 30 min at room temperature, 
and washed with liposome buffer. A volume of 30 µl 
liposome (30 nmol lipids) and purified proteins (~1.5 
pmol) were mixed in 50 µl of 10% OptiPrep buffer 
(20 mM HEPES-KOH, pH 7.5, 150 mM KCl, 10% 
OptiPrep [Abbott Diagnostics Technologies, 1114542]) 
in microcentrifuge tubes. After incubating for 45 min at 
4°C, the liposome solutions were adjusted to 35% 
OptiPrep by adding 50 µl of 60% OptiPrep, and then 
400 µl of 30% OptiPrep buffer (20 mM HEPES-KOH, 
pH 7.5, 150 mM KCl, 30% OptiPrep) and 100 µl of 
liposome buffer were sequentially overlaid (total 
600 µl). Samples were centrifuged at 50,000 × g, 4°C 
for 2 h using a CS150GXII (Hitachi Koki). Liposomes 
were visually confirmed by fluoPE fluorescence. The 
600 µl solution was divided into 3 equivalent fractions 
(i.e. bottom, middle, and top) by collecting 200 µl ali-
quots from the bottom of the tube using a micro- 
syringe (Hamilton). SDS-PAGE sample buffer was 
added for western blotting.
Quantification of autophagy foci following amino-acid 
starvation and mitophagy
All images for quantification were acquired under constant 
excitation strength using a confocal microscope (LSM780) 
and ZEN software. “The number of BCAS3 foci per cell”, 
“The relative area of BCAS3 foci per cell” in Figure 6E, “The 
relative area of foci per cell” in Figure 10E and Fig. S7E, and 
“The relative mtDNA intensity per cell” in Fig. S6B and S6D 
were calculated using the Analyze Particles program provided 
with ImageJ. Non-specific signals were removed by adjusting 
the lower threshold level. The number of DAPI stained nuclei 
in the same area were counted and considered as equivalent to 
the number of cells.
FACS-based mitophagy flux analysis
Cells stably expressing YFP-PRKN and mitochondria- 
targeted Keima (mt-Keima) were grown in a 6-well plate 
and treated with or without 4 µM antimycin A, 10 µM 
oligomycin and 10 µM Q-VD-OPh for 9 h. The cells were 
then washed with PBS and resuspended with PBS containing 
2.5% (v:v) FBS in a polystyrene Round-Bottom Tube 
(Falcon, 352235). Analysis was performed using FACSDiva 
software on a BD LSRFortessa X-20 cell sorter (BD 
Biosciences). mKeima fluorescence was determined based 
on dual-excitation ratiometric pH measurements using 405- 
nm (pH 7) and 561-nm (pH 4) lasers with 610/20-nm 
emission filters. For each sample, 10,000 YFP/mt-Keima 
double positive cells were collected.
Statistical analysis
Statistical differences between control groups and experimen-
tal groups were determined as p-values (P) based on student’s 
t-test using data obtained from three independent experi-
ments. (n.s.: not significant, *P < 0.05, **P < 0.01, 
***P < 0.001)
Comparative modeling of WD40 repeat domain of BCAS3
The structural model of the BCAS3 WD40 repeat domain was 
constructed based on the K. lactis Hsv2 structure (PDB ID: 
4EXV) using the homology model application in MOE 
2018.0101 (Chemical Computing Group). The alignment 
used in the structural model was obtained based on an 
HHpred [60] prediction with global alignment mode. We 
used the WD40 repeat domain sequence without the two 
insertions (residues 254–312 and 437–560) as the query 
sequence for HHpred.
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